/

Workspace

Research & Review

Writing & Publishing

Data & Analysis

Utilities

Account

User Settings

L

Lucrecia Boland

Center for Cancer Research(US)

Claim or correct this author profile

Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.

19

Papers

10

Citations

2

h-index

0

i10-index

Lucrecia Boland is an academic researcher from Center for Cancer Research. The author has contributed to research in topics: Lung Cancer Treatments and Mutations & Organizational Management and Innovation & HER2/EGFR in Cancer Research. The author has an h-index of 2, co-authored 17 publications.

Research Topics

Lung Cancer Treatments and Mutations Organizational Management and Innovation HER2/EGFR in Cancer Research Higher Education Teaching and Evaluation Medical Imaging Techniques and Applications

Papers by this author

works

STX-721, a Covalent EGFR/HER2 Exon 20 Inhibitor, Utilizes Exon 20–Mutant Dynamic Protein States and Achieves Unique Mutant Selectivity Across Human Cancer Models

2025 · Clinical Cancer Research · 4 citations

https://doi.org/10.1158/1078-0432.ccr-24-3833

Raymond A. Pagliarini Jack A. Henderson Benjamin C. Milgram Deanna R. Borrelli

Research topics

topics

Lung Cancer Treatments and Mutations

Organizational Management and Innovation

HER2/EGFR in Cancer Research

Higher Education Teaching and Evaluation

Medical Imaging Techniques and Applications

Chat about Author

Papers

Chat

Click to start Chat